Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC5A2 mRNA | affects expression | 16483693
|
D002945 |
Cisplatin |
[Cisplatin results in decreased expression of HNF1A mRNA] which results in decreased expression of SLC5A2 mRNA | decreases expression | 18656965
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of SLC5A2 mRNA | decreases expression | 18656965
|
D002945 |
Cisplatin |
[Cisplatin results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose | affects transport|decreases expression | 18656965
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SLC5A2 mRNA | affects expression | 17555576
|
D005839 |
Gentamicins |
[Gentamicins results in decreased expression of HNF1A mRNA] which results in decreased expression of SLC5A2 mRNA | decreases expression | 18656965
|
D005839 |
Gentamicins |
Gentamicins results in decreased expression of SLC5A2 mRNA | decreases expression | 18656965
|
D005839 |
Gentamicins |
[Gentamicins results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose | affects transport|decreases expression | 18656965
|
D005947 |
Glucose |
[Cisplatin results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose | affects transport|decreases expression | 18656965
|
D005947 |
Glucose |
EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] | decreases reaction|increases uptake | 15127950
|
D005947 |
Glucose |
[Gentamicins results in decreased expression of SLC5A2 mRNA] which affects the transport of Glucose | affects transport|decreases expression | 18656965
|
D005947 |
Glucose |
NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] | decreases reaction|increases uptake | 15127950
|
D012402 |
Rotenone |
Rotenone results in decreased expression of SLC5A2 mRNA | decreases expression | 19013527
|
C446685 |
systhane |
systhane results in increased expression of SLC5A2 mRNA | increases expression | 16643972
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC5A2 protein | decreases expression | 15582352
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
9.96 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
9.96 | 11274264 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
4.63 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.63 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
5.26 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.16 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.16 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
2.44 | 17982673 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.10 | 16685392 12023789 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
2.87 | 17066447 6189445 18337622 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 18670907 16120746 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 17110522 16105132 17333356 11677210 15861022 17681005 16919318 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.33 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
14.92 | 12649298 12231392 19839026 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
14.92 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
14.92 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.47 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
2.83 | 15464296 17638652 15173087 16481741 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.05 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D006030 |
Glycosuria, Renal |
marker/mechanism |
|
| |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.87 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
11.02 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
11.02 | 17868369 15968427 18024279 19130971 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.62 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
9.95 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.95 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.80 | 16170182 16200630 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
6.04 | 17652376 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
14.61 | 15464296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
14.61 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
7.15 | 12649298 18289764 12231392 15190930 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
7.15 | 17934191 19349640 18289764 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
13.30 | 11231351 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
13.30 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.66 | 10219319 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
6.73 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.73 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
2.52 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.52 | 19555203 11884234 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
4.03 | 18176117 17761969 18332650 16248763 12883367 16809738 12374674 12393984 17023156 15577323 11135225 18505091 16432458 |
MESH:D008545 |
Melanoma |
|
Glucose |
4.03 | 14993021 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
5.11 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.32 | 17638057 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.65 | 18694830 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
3.04 | 16773208 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.87 | 15464296 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.06 | 17356569 18619942 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.56 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
5.03 | 8761367 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
2.93 | 19769630 17225452 15464296 6897625 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
3.06 | 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.05 | 19232380 19114014 18619942 16140633 11445065 15451049 11535288 16412576 18191903 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.30 | 15927086 15574749 18197244 15795934 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.59 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.72 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11896295 11222880 11399792 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.98 | 15033597 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
11.71 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
11.71 | 15728788 17132701 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.65 | 18644591 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.71 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
6.31 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.31 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.72 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.33 | 18396642 17522103 15958060 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.89 | 17225452 15464296 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
3.02 | 15464296 12973940 17225452 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.43 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.92 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 15869587 14671159 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.80 | 18776599 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
5.09 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |